Blog
RSS FeedPosted by Michael Wonder on 06 Sep 2022
COVID-19: a global opinion on bivalent vaccines in mid-September
5 September 2022 - The EMA has just modified the marketing authorisations granted to messenger RNA vaccines developed by Moderna and ...
Posted by Michael Wonder on 06 Sep 2022
Sanofi sees EU regulatory decision on its COVID booster in weeks
5 September 2022 - The European Union's drugs regulator may be a few weeks from deciding whether to approve the ...
Posted by Michael Wonder on 06 Sep 2022
Swissmedic authorizes Novavax Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 and as a booster in adults aged 18 and older
5 September 2022 - Novavax, today announced that Swissmedic has expanded its temporary authorisation of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in Switzerland ...
Posted by Michael Wonder on 03 Sep 2022
Pfizer/BioNTech bivalent COVID-19 booster approved by UK medicines regulator
3 September 2022 - The adapted COVID-19 vaccine targets both the original virus and the Omicron variant. ...
Posted by Michael Wonder on 03 Sep 2022
ATAGI update following weekly COVID-19 meeting (31 August 2022)
2 September 2022 - An update from the Australian Technical Advisory Group on Immunisation following their weekly meeting on 31 August ...
Posted by Michael Wonder on 03 Sep 2022
Swissmedic authorises Novavax Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 and as a booster in adults aged 18 and older
2 September 2022 - Novavax today announced that Swissmedic has expanded its temporary authorisation of Nuvaxovid COVID-19 vaccine in Switzerland for ...
Posted by Michael Wonder on 01 Sep 2022
EMA CHMP adopts positive opinion recommending authorisation for the use of Moderna's Omicron targeting bivalent booster in the European Union
1 September 2022 - Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 sub-variants when ...
Posted by Michael Wonder on 01 Sep 2022
Health Canada authorises first bivalent COVID-19 booster for adults 18 years and older
1 September 2022 - Today, Health Canada authorised an adapted version of the Moderna Spikevax COVID-19 vaccine. ...
Posted by Michael Wonder on 01 Sep 2022
First adapted COVID-19 booster vaccines recommended for approval in the EU
1 September 2022 - The EMA’s CHMP has recommended authorising two vaccines adapted to provide broader protection against COVID-19. ...
Posted by Michael Wonder on 31 Aug 2022
FDA authorises Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose
31 August 2022 - Today, the US FDA amended the emergency use authorisations of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech ...
Posted by Michael Wonder on 30 Aug 2022
Evusheld long-acting antibody combination approved for prevention and treatment of COVID-19 in Japan
30 August 2022 - First global approval for Evusheld as a COVID-19 treatment. ...
Posted by Michael Wonder on 30 Aug 2022
TGA provisionally approves Moderna bivalent COVID-19 vaccine for use as a booster dose in adults
30 August 2022 - On 29 August 2022, the TGA provisionally approved Moderna's bivalent COVID-19 vaccine, elasomeran with imelasomeran (Spikevax Bivalent ...
Posted by Michael Wonder on 30 Aug 2022
COVID-19 vaccines undergoing evaluation (30 August 2022)
30 August 2022 - The TGA has updated its list of the applications it has received for COVID-19 vaccines using the ...
Posted by Michael Wonder on 30 Aug 2022
Swissmedic authorises Moderna's Omicron targeting bivalent booster candidate MRNA-1273.214
29 August 2022 - Switzerland becomes among the first countries in the world to approve the use of a next-generation ...
Posted by Michael Wonder on 29 Aug 2022
FDA expected to authorise Moderna, Pfizer-BioNTech Omicron boosters
29 August 2022 - The move would set the stage for the Biden administration to begin offering the reformulated vaccine shortly ...